無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医療機器向けナノテクノロジーの世界市場 (2019年まで):製品別 (バイオチップ、インプラント材料、医療用繊維、創傷被膜、心調律管理 (CRM) デバイス、補聴器) ・用途別の将来予測

Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019

発行 MarketsandMarkets 商品コード 326425
出版日 ページ情報 英文 178 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
医療機器向けナノテクノロジーの世界市場 (2019年まで):製品別 (バイオチップ、インプラント材料、医療用繊維、創傷被膜、心調律管理 (CRM) デバイス、補聴器) ・用途別の将来予測 Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019
出版日: 2015年03月18日 ページ情報: 英文 178 Pages
概要

ナノテクノロジーを活用した医療機器の市場は、世界各国の人口高齢化や心血管疾患の患者増加、骨・耳などの臓器系の疾患患者増大などを背景に、近年急速な成長を遂げています。しかし、ナノテクノロジー活用型の医療機器はコストも高く、また認証にかかる時間も長いため、今後の市場成長率は限られた水準に留まる見通しです。地域別に見ると、北米が世界最大の市場で、欧州がそれに続いています。一方で、アジア太平洋地域諸国も急速な成長を遂げています。企業別に見ると、上位6社で市場の65〜70%を占めていますが、新規参入企業に市場を奪われる可能性もあるため、市場シェアの維持を目指して様々な戦略に取り組んでいます。

当レポートでは、全世界の医療用ナノテクノロジー技術・製品の市場について分析し、技術の概要や基本的な市場構造、主な市場促進・阻害要因、製品別・用途別・地域別の詳細な市場動向、市場競争の状態、今後の技術開発・市場発展の方向性、主要企業のプロファイルなどを調査・考察しております。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場区分
    • ナノテクノロジー活用型医療機器市場:種類別
    • ナノテクノロジー活用型医療機器市場:用途別
  • 市場の主なダイナミクス
    • 市場促進要因
      • 政府の支援強化
      • 老年人口の増加
    • 市場抑制要因
      • 厳格で時間がかかる製品承認過程
      • 高額のナノテクノロジー活用型医療機器
    • 市場機会
      • 治験中期・後期段階のパイプライン製品の層の厚さ
      • 新興国市場の高い成長機会
    • 市場の課題
      • ナノテクノロジー活用型装置の事業化
      • 不適切な基準と、規制承認枠組みの欠如

第6章 産業動向

  • イントロダクション
  • 産業動向
  • ポーターのファイブフォース分析
  • 戦略的ベンチマーキング
    • 新製品の市場投入および製品の強化

第7章 世界のナノテクノロジー活用型医療機器市場:製品別の区分

  • イントロダクション
  • 能動埋め込み型医療機器
    • 心調律管理 (CRM) 装置
    • 補聴器装置
    • 網膜移植片
  • バイオチップ
    • DNAマイクロアレイ
    • ラブオンチップ
  • 移植可能材料
    • 歯科用修復材料
    • 代用骨材料
  • 医療用テキスタイルおよび創傷被覆材
  • その他

第8章 ナノテクノロジー活用型医療機器市場:用途別

  • イントロダクション
  • 治療用
  • 診断用
  • 研究用

第9章 世界のナノテクノロジー活用型医療機器市場:地域区分

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州諸国
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • その他のアジア太平洋地域
  • その他の地域 (ROW)
    • ラテンアメリカ
    • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 市場シェア分析:世界のナノテクノロジー医療機器市場
  • 競合状況・動向
  • 新製品の市場投入
  • 規模拡大
  • 契約・提携・共同開発・合弁会社
  • 企業合併・買収 (M&A)

第11章 企業プロファイル

  • イントロダクション
  • 3M Company
    • 事業概要
    • 製品ポートフォリオ
    • 主要戦略
    • 最近の発展動向
  • Dentsply International
  • 三井化学
  • Stryker Corporation
  • AAP Implantate AG
  • Affymetrix Inc.
  • Perkinelmer, Inc.
  • ST. Jude Medical Inc.
  • Smith & Nephew PLC
  • Starkey Hearing Technologies

第12章 付録

図表一覧

目次
Product Code: MD 3248

Over the last five years, the nanotechnology-based medical devices market witnessed tremendous growth primarily due to growth in the aging population, and increasing government support with increased nanotechnology R&D expenditure and increased international research collaborations.

In this report, the global nanotechnology-based medical devices market is segmented on the basis of products and applications. On the basis products, the nanotechnology-based medical devices market is categorized into biochips, implantable materials, medical textile and wound dressing, active implantable devices, and others. The implantable materials segment is bifurcated into dental filling materials and bone restorative materials; whereas, the active implantable devices segment is bifurcated into cardiac rhythm management devices, hearing aid devices, and retinal implants. On the basis of applications, the nanotechnology-based medical devices market is segmented into therapeutics applications, diagnostics applications, and research applications.

The global nanotechnology-based medical devices market is expected to grow at a significant CAGR of around 11-12% during the forecast period (2014-2019). The market is mainly driven by the growth in aging population, rising adoption of nanotechnology-based medical devices, and increased nanotechnology R&D expenditure. In addition, the governments of several nations are investing heavily in developing and commercializing new nanotechnology products. However, safety issues regarding nanotechnology-based medical devices, stringent regulatory guidelines, and time-consuming approval processes for these devices are hampering the growth of this market to a certain extent.

Active implantable devices accounted for a major share of the nanotechnology-based medical devices the market. The nanotechnology-based medical devices market for active implantable devices is primarily driven by the growing incidence of age-related disorders such as hearing and cardiovascular disorders. In addition, the growing awareness about these diseases and increased acceptance of the hearing aid devices are further driving the market for active implantable devices.

In 2013, North America accounted for the largest share to the global nanotechnology-based medical devices market, followed by Europe, Asia-Pacific, and RoW. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the rapidly aging population, rising adoption of advanced nanotechnology-based medical devices, increased accessibility to healthcare facilities, and rising R&D and healthcare expenditure.

The global nanotechnology-based medical devices market is dominated by six players that accounted for around 65-70% of the global market in 2014. The major players in the global nanotechnology-based medical devices market are Stryker Corporation (U.S.), 3M Company (U.S.), St. Jude Medical, Inc. (U.S.), Affymetrix, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Starkey Hearing Technologies (U.S.), and Smith & Nephew plc (U.K.).

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the nanotechnology-based medical devices market. The report analyzes the nanotechnology-based medical devices market by products and applications across all regions
  • Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the nanotechnology-based medical devices market
  • Market Development: Comprehensive information on the lucrative emerging markets by product, application, and region
  • Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the nanotechnology-based medical devices market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the nanotechnology-based medical devices market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Markets Covered
  • 1.3. Stakeholders
  • 1.4. Market Scope

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Market Size Estimation
  • 2.3. Market Crackdown and Data Triangulation
  • 2.4. Market Share Estimation
  • 2.5. Key Secondary Sources
  • 2.6. Key Data From Primary Sources
    • 2.6.1. Key Industry Insights
  • 2.7. Assumptions for the Study

3. Executive Summary

4. Premium Insights

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Nanotechnology-Based Medical Devices Market, By Type
    • 5.2.2. Nanotechnology-Based Medical Devices Market, By Application
  • 5.3. Key Market Dynamics
    • 5.3.1. Market Drivers
      • 5.3.1.1. Increasing Government Support
      • 5.3.1.2. Growing Geriatric Population
    • 5.3.2. Market Restraints
      • 5.3.2.1. Stringent and Time-Consuming Product Approval Processes
      • 5.3.2.2. High Prices of Nanotechnology-Based Medical Devices
    • 5.3.3. Market Opportunities
      • 5.3.3.1. Rich Mid-To-Late Stage Product Pipeline
      • 5.3.3.2. High Growth Opportunities in Emerging Markets
    • 5.3.4. Market Challenges
      • 5.3.4.1. Commercialization of Nanotechnology-Based Devices
      • 5.3.4.2. Inadequate Standards and Lack of Regulatory Approval Frameworks

6. Industry Trends

  • 6.1. Introduction
  • 6.2. Industry Trends
  • 6.3. Porter's Five Forces Analysis
    • 6.3.1. Threat From New Entrants
    • 6.3.2. Threat From Substitutes
    • 6.3.3. Bargaining Power of Suppliers
    • 6.3.4. Bargaining Power of Buyers
    • 6.3.5. Intensity of Competitive Rivalry
  • 6.4. Strategic Benchmarking
    • 6.4.1. New Product Launches and Product Enhancements

7. Global Nanotechnology-Based Medical Devices Market, By Product

  • 7.1. Introduction
  • 7.2. Active Implantable Devices
    • 7.2.1. Cardiac Rhythm Management Devices
    • 7.2.2. Hearing Aid Devices
    • 7.2.3. Retinal Implants
  • 7.3. Biochips
    • 7.3.1. Dna Microarrays
    • 7.3.2. Lab-On-Chip
  • 7.4. Implantable Materials
    • 7.4.1. Dental Restorative Materials
    • 7.4.2. Bone Substitute Materials
  • 7.5. Medical Textiles and Wound Dressings
  • 7.6. Others

8. Nanotechnology-Based Medical Devices Market, By Application

  • 8.1. Introduction
  • 8.2. Therapeutic Applications
  • 8.3. Diagnostic Applications
  • 8.4. Research Applications

9. Global Nanotechnology-Based Medical Devices Market, By Region

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Rest of the World (ROW)
    • 9.5.1. Latin America
    • 9.5.2. Middle East and Africa

10. Competitive Landscape

  • 10.1. Overview
  • 10.2. Market Share Analysis, Global Nanotechnology Medical Devices Market
  • 10.3. Competitive Situation and Trends
  • 10.4. New Product Launches
  • 10.5. Expansions
  • 10.6. AGreements, Partnerships, Collaborations, & Joint Ventures
  • 10.7. Mergers and Acquisit Ions

11. Company Profiles

  • 11.1. Introduction
  • 11.2. 3M Company
    • 11.2.1. Business Overview
    • 11.2.2. Product Portfolio
    • 11.2.3. Key Strategy
    • 11.2.4. Recent Developments
  • 11.3. Dentsply International
    • 11.3.1. Business Overview
    • 11.3.2. Product Portfolio
    • 11.3.3. Key Strategy
    • 11.3.4. Recent Developments
  • 11.4. Mitsui Chemicals, Inc.
    • 11.4.1. Business Overview
    • 11.4.2. Product Portfolio
    • 11.4.3. Key Strategy
    • 11.4.4. Recent Developments
  • 11.5. Stryker Corporation
    • 11.5.1. Business Overview
    • 11.5.2. Product Portfolio
    • 11.5.3. Key Strategy
    • 11.5.4. Recent Developments
  • 11.6. AAP Implantate AG
    • 11.6.1. Business Overview
    • 11.6.2. Product Portfolio
    • 11.6.3. Key Strategy
    • 11.6.4. Recent Developments
  • 11.7. Affymetrix, Inc.
    • 11.7.1. Business Overview
    • 11.7.2. Product Portfolio
    • 11.7.3. Key Strategy
    • 11.7.4. Recent Developments
  • 11.8. Perkinelmer, Inc.
    • 11.8.1. Business Overview
    • 11.8.2. Product Portfolio
    • 11.8.3. Key Strategy
    • 11.8.4. Recent Developments
  • 11.9. ST. Jude Medical, Inc.
    • 11.9.1. Business Overview
    • 11.9.2. Product Portfolio
    • 11.9.3. Key Strategy
    • 11.9.4. Recent Developments
  • 11.1. Smith & Nephew PLC
    • 11.10.1. Business Overview
    • 11.10.2. Product Portfolio
    • 11.10.3. Key Strategy
    • 11.10.4. Recent Developments
  • 11.11. Starkey Hearing Technologies
    • 11.11.1. Business Overview
    • 11.11.2. Product Portfolio
    • 11.11.3. Key Strategy
    • 11.11.4. Recent Developments

12. Appendix

  • 12.1. Insights of Industry Experts
  • 12.2. Available Customizations
  • 12.3. Related Reports
  • 12.4. Introducing RT: Real Time Market Intelligence

List of Tables

  • Table 1: Global Nanotechnology in Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 2: Global Nanotechnology in Medical Devices Market Size, By Geography, 2012-2019 ($Million)
  • Table 3: Global Nanotechnology in Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 4: Global Nanotechnology-Based Active Implantable Devices Market Size, By Geography, 2012-2019 ($Million)
  • Table 5: Global Nanotechnology-Based Cardiac Rhythm Management Devices Market Size, By Geography, 2012-2019 ($Million)
  • Table 6: Global Nanotechnology-Based Hearing Aid Devices Market Size, By Geography, 2012-2019 ($Million)
  • Table 7: Global Nanotechnology-Based Retinal Implants Market Size, By Geography, 2012-2019 ($Million)
  • Table 8: Global Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 9: Global Nanotehcnology-Based Biochips Market Size, By Geography, 2012-2019 ($Million)
  • Table 10: Global Nanotechnology-Based DNA Microarrays Market Size, By Geography, 2012-2019 ($Million)
  • Table 11: Global Nanotechnology-Based Lab-On-Chip Market Size, By Geography, 2012-2019 ($Million)
  • Table 12: Global Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 13: Global Nanotechnology-Based Implantable Materials Market Size, By Geography, 2012-2019 ($Million)
  • Table 14: Global Nanotechnology-Based Dental Filling Materials Market Size, By Geography, 2012-2019 ($Million)
  • Table 15: Global Nanotechnology-Based Bone Substitute Materials Market Size, By Geography, 2012-2019 ($Million)
  • Table 16: Global Nanotechnology-Based Medical Textiles and Wound Dressings Market Size, By Geography, 2012-2019 ($Million)
  • Table 17: Global Other Nanotechnology-Based Medical Devices Market Size, By Geography, 2012-2019 ($Million)
  • Table 18: Global Nanotechnology in Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 19: Global Nanotechnology in Medical Devices Market Size, By Geography, 2012-2019 ($Million)
  • Table 20: Global Nanotehcnology in Medical Devices Market Size for Therapeutic Applications, By Geography, 2012-2019 ($Million)
  • Table 21: Global Nanotechnology in Medical Devices Market Size for Diagnostic Applications, By Geography, 2012-2019 ($Million)
  • Table 22: Global Nanotechnology in Medical Devices Market Size for Research Applications, By Geography, 2012-2019 ($Million)
  • Table 23: North America: Nanotechnology in Medical Devices Market Size, By Country, 2012-2019 ($Million)
  • Table 24: North America: Nanotechnology in Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 25: North America: Nanotechnology in Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 26: North America: Nanotechnology in Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 27: North America: Nanotechnology in Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 28: North America: Nanotechnology in Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 29: U.S.: Nanotechnology in Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 30: U.S.: Nanotechnology in Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 31: U.S.: Nanotechnology in Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 32: U.S.: Nanotechnology in Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 33: U.S.: Nanotechnology in Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 34: Canada: Nanotechnology in Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 35: Canada: Nanotechnology in Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 36: Canada: Nanotechnology in Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 37: Canada: Nanotechnology in Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 38: Canada: Nanotechnology in Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 39: Europe: Nanotechnology in Medical Devices Market Size, By Country/Region, 2012-2019 ($Million)
  • Table 40: Europe: Nanotechnology-Based Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 41: Europe: Nanotechnology in Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 42: Europe: Nanotechnology in Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 43: Europe: Nanotechnology in Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 44: Europe: Nanotechnology in Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 45: Germany: Nanotechnology in Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 46: Germany: Nanotechnology in Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 47: Germany: Nanotechnology in Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 48: Germany: Nanotechnology in Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 49: Germany: Nanotechnology in Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 50: France: Nanotechnology in Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 51: France: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 52: France: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 53: France: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 54: France: Nanotechnology in Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 55: U.K.: Nanotechnology in Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 56: U.K.: Nanotechnology in Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 57: U.K.: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 58: U.K.: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 59: U.K.: Nanotechnology in Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 60: Italy: Nanotechnology in Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 61: Italy: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 62: Italy: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 63: Italy: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 64: Italy: Nanotechnology in Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 65: Spain: Nanotechnology in Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 66: Spain: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 67: Spain: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 68: Spain: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 69: Spain: Nanotechnology in Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 70: Rest of Europe: Nanotechnology-Based Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 71: Rest of Europe: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 72: Rest of Europe: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 73: Rest of Europe: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 74: Rest of Europe: Nanotechnology-Based Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 75: Asia-Pacific: Nanotechnology-Based Medical Devices Market Size, By Country/Region, 2012-2019 ($Million)
  • Table 76: Asia-Pacific: Nanotechnology-Based Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 77: Asia-Pacific: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 78: Asia-Pacific: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 79: Asia-Pacific: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 80: Asia-Pacific: Nanotechnology-Based Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 81: Japan: Nanotechnology-Based Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 82: Japan: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 83: Japan: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 84: Japan: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 85: Japan: Nanotechnology-Based Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 86: China: Nanotechnology-Based Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 87: China: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 88: China: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 89: China: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 90: China: Nanotechnology-Based Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 91: India: Nanotechnology-Based Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 92: India: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 93: India: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 94: India: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 95: India: Nanotechnology-Based Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 96: ROAPAC: Nanotechnology-Based Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 97: ROAPAC: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 98: ROAPAC: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 99: ROAPAC: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 100: ROAPAC: Nanotechnology-Based Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 101: ROW: Nanotechnology-Based Medical Devices Market Size, By Region, 2012-2019 ($Million)
  • Table 102: ROW: Nanotechnology-Based Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 103: ROW: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 104: ROW: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 105: ROW: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 106: ROW: Nanotechnology-Based Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 107: Latin America: Nanotechnology-Based Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 108: Latin America: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 109: Latin America: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 110: Latin America: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 111: Latin America: Nanotechnology-Based Medical Devices Market Size, By Application, 2012-2019 ($Million)
  • Table 112: Middle East and Africa: Nanotechnology-Based Medical Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 113: Middle East and Africa: Nanotechnology-Based Biochips Market Size, By Type, 2012-2019 ($Million)
  • Table 114: Middle East and Africa: Nanotechnology-Based Implantable Materials Market Size, By Type, 2012-2019 ($Million)
  • Table 115: Middle East and Africa: Nanotechnology-Based Active Implantable Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 116: Middle East and Africa: Nanotechnology-Based Medical Devices Market Size, By Application, 2012-2019 ($Million)

List of Figures

  • Figure 1: Global Nanotechnology Medical Devices Market
  • Figure 2: Nanotechnology Medical Devices Research Methodology
  • Figure 3: Break Down of Primary Interviews: By Company Type, Designation, and Region
  • Figure 4: Bottom-Up Approach
  • Figure 5: Top-Down Approach
  • Figure 6: Data Triangulation Methodology
  • Figure 7: Global Nanotechnology Medical Devices Market Size, By Power Source, 2014 vs. 2019 ($Million)
  • Figure 8: Global Nanotechnology Medical Devices Market Size, By Type, 2014 vs. 2019 ($Million)
  • Figure 9: Global Nanotechnology Medical Devices Market Size, By Application, 2014 vs. 2019 ($Million)
  • Figure 10: Global Nanotechnology Medical Devices Market Share, 2013
  • Figure 11: Nanotechnology-Based Medical Devices Market Segmentation, By Type
  • Figure 12: Nanotechnology-Based Medical Devices Market Segmentation, By Application
  • Figure 13: Increasing Government Support to Spur the Demand for Nanotechnology-Based Medical Devices
  • Figure 14: Porter's Five Forces Analysis (2014): Increasing Number of Local and Regional Players is Enhancing Competition in the Industry
  • Figure 15: Strategic Benchmarking: Major Players Adopted Product Launches and Product Enhancement Strategies
  • Figure 16: New Product Launches Was Key Strategy in Last Three Years
  • Figure 17: Global Nanotechnology Medical Devices Market Share Analysis, By Key Player, 2013
  • Figure 18: Battle for Market Share: New Product Launches Was the Key Strategy
  • Figure 19: Geographic Revenue Mix of Top 5 Market Players
  • Figure 20: 3M Company: Company Snapshot
  • Figure 21: Dentsply International: Company Snapshot
  • Figure 22: Mitsui Chemicals, Inc.: Company Snapshot
  • Figure 23: Stryker Corporation: Company Snapshot
  • Figure 24: AAP Implantate AG: Company Snapshot
  • Figure 25: Affymetrix, Inc.: Company Snapshot
  • Figure 26: Perkinelmer, Inc.: Company Snapshot
  • Figure 27: ST. Jude Medical, Inc.: Company Snapshot
  • Figure 28: Smith & Nephew PLC: Company Snapshot
Back to Top